RICS, a Novel GTPase-activating Protein for Cdc42 and Rac1, Is Involved in the beta -Catenin-N-cadherin and N-Methyl-D-aspartate Receptor Signaling*

Toshio OkabeDagger §, Tsutomu NakamuraDagger , Yukiko Nasu NishimuraDagger , Kazuyoshi KohuDagger , Susumu Ohwada§, Yasuo Morishita§, and Tetsu AkiyamaDagger ||

From the Dagger  Laboratory of Molecular and Genetic Information, Institute for Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan and § Second Department of Surgery, Gunma University School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371, Japan

Received for publication, August 29, 2002, and in revised form, January 14, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cadherin adhesion molecules are believed to be important for synaptic plasticity. beta -Catenin, which links cadherins and the actin cytoskeleton, is a modulator of cadherin adhesion and regulates synaptic structure and function. Here we show that beta -catenin interacts with a novel GTPase-activating protein, named RICS, that acts on Cdc42 and Rac1. The RICS-beta -catenin complex was found to be associated with N-cadherin, N-methyl-D-aspartate receptors, and postsynaptic density-95, and localized to the postsynaptic density. Furthermore, the GTPase-activating protein activity of RICS was inhibited by phosphorylation by Ca2+/calmodulin-dependent protein kinase II. These results suggest that RICS is involved in the synaptic adhesion- and N-methyl-D-aspartate-mediated organization of cytoskeletal networks and signal transduction. Thus, RICS may regulate dendritic spine morphology and strength by modulating Rho GTPases.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Activity-induced changes in synaptic transmission efficacy, such as long term potentiation (LTP)1 and long term depression, have been postulated to be involved in information storage during learning. Many studies have revealed that synaptic remodeling and plastic changes in dendritic spine morphology play a role in synaptic plasticity (1-6). Furthermore, changes in synaptic strength have been shown to involve the structural and functional modifications of the molecules present in the postsynaptic density (PSD) (7-10), an electrondense structure containing various structural and signaling molecules such as ion channels, scaffolding proteins, protein kinases, small G-proteins, cell adhesion proteins, and cytoskeletal proteins (11, 12).

The cadherins are a family of single-pass transmembrane proteins that mediate Ca2+-dependent, homophilic intercellular adhesion (13). Some members of the cadherin family of adhesion proteins are localized to synaptic junctions and have been implicated in synaptic plasticity (14, 15). For example, inhibitory antibodies to the first extracellular domain of N-cadherin, one of the classical cadherins enriched in neural cells, have been shown to attenuate the induction of LTP (16, 17). Also, antagonistic peptides containing the consensus sequence for cadherin dimer formation prevent the induction of LTP (16). Furthermore, inhibition of cadherin activity by a dominant-negative N-cadherin, as well as by mutation of alpha N-catenin, has been shown to alter dendritic spine morphology (18), suggesting that cadherins function as regulators of synaptic plasticity by modulating spine morphology.

beta -Catenin interacts with the cytoplasmic domain of classical cadherins and links cadherins and the actin cytoskeleton (19, 20). beta -Catenin and N-cadherin are present in axons and dendrites prior to synapse formation and then cluster at developing synapses and form a symmetrical adhesion structure in synaptic junctions (21). Moreover, it has been reported recently (10) that neural activity induces redistribution of beta -catenin from dendritic shafts into spines, where it interacts with cadherin to influence synaptic size and strength.

N-Methyl-D-aspartate (NMDA) receptors, which play a central role in synaptic plasticity, are heteromeric ion channels consisting of essential NR1 subunits and one or more of the modulatory NR2 subunits, NR2A-D (22-24). The NMDA receptors are associated with the PSD-95 family of proteins, the most abundant constituents of PSD, via its NR2 subunits (25-28). This interaction is important for specific localization of NMDA receptors in the PSD and its coupling to cytoskeletal networks and signaling molecules (29-33). beta -Catenin is also known to be localized in PSD as a component of the NMDA receptor multiprotein complex (12). Furthermore, the beta -catenin redistribution induced by depolarization is completely blocked by NMDA receptor antagonists, indicating that the redistribution is caused by synaptic activation of NMDA receptors (10). Also it has been reported that stimulation of NMDA receptors by the agonist NMDA induces molecular modification of N-cadherin, i.e. increased trypsin resistance, as well as pronounced dimerization of N-cadherin (7). Thus, beta -catenin and N-cadherin are structurally and functionally linked to NMDA receptors.

To further elucidate the role of beta -catenin in synaptic function, we attempted to identify novel binding partners of beta -catenin. In the present study, we show that beta -catenin interacts with a novel GTPase-activating protein for Cdc42 and Rac1, termed RICS (RhoGAP involved in the beta -catenin-N-cadherin and NMDA receptor signaling). RICS was found to localize to the PSD and to be associated with N-cadherin, PSD-95, and NMDA-R, in addition to beta -catenin. Furthermore, we demonstrate that its GAP activity is down-regulated through phosphorylation by Ca2+/calmodulin-dependent protein kinase II (CaMKII), a kinase critical for synaptic plasticity that is activated by NMDA receptor-mediated influx of Ca2+ (34).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmid Construction-- The human RICS cDNA clone KIAA0712 was provided by T. Nagase (Kazusa DNA Research Institute) and subcloned into the mammalian expression vector pcDNA3.1(+) (Invitrogen). Mutant RICSs were generated by PCR. The authenticity of all mutants was verified by DNA sequencing. For retrovirus-mediated expression of RICS, the RICS cDNA was inserted into pMX-puro, provided by T. Kitamura.

Two-hybrid Screening-- Two-hybrid screening was performed as described previously (43).

In Vitro Binding Assay-- [35S]Methionine-labeled RICS was synthesized by in vitro transcription-translation using the TNTTM-coupled reticulocyte lysate system (Promega). Proteins fused to glutathione S-transferase (GST) were synthesized in Escherichia coli and isolated by absorption to GSH-Sepharose (Amersham Biosciences). GST fusion proteins immobilized to beads were incubated with in vitro translation products in Buffer A (0.1% Triton X-100, 10 mM Tris-HCl, 140 mM NaCl, 1 mM EDTA, 1 mM sodium vanadate, 50 mM NaF, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM p-amidinophenylmethanesulfonyl fluoride hydrochloride, pH 8.0) and then washed extensively with Buffer A. Proteins adhering to the beads were analyzed by SDS-PAGE followed by autoradiography.

Preparation of PSDs from Mouse Brain-- The PSD fractions were isolated from mouse brain following the protocols described previously (76, 77). Briefly, adult mouse brains were homogenated in an ice-cold solution containing 0.32 M sucrose, 1 mM HEPES-KOH, pH 7.4, 1 mM NaHCO3, 1 mM MgCl2, 0.1 mM phenylmethanesulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM NaF, and 1 mM Na3VO4 and centrifuged at 1,000 × g and then 13,800 × g each for 10 min. The resulting pellet was further fractionated by discontinuous sucrose density gradient centrifugation at 82,500 × g for 2 h to obtain the synaptosome fraction. The synaptosome fraction was solubilized with 0.5% Triton X-100, and the PSD (One Triton) pellet was collected by centrifugation at 82,500 × g for 30 min. The PSD (One Triton) pellet was re-extracted in 0.5% Triton X-100 and centrifuged at 201,800 × g for 1 h to obtain the PSD (Two Triton) pellet. Alternatively, the PSD (One Triton) pellet was treated with 3% N-lauroylsarcosinate and then centrifuged at 201,800 × g for 1 h to obtain the PSD (One Triton + Sarcosyl) pellet. All pellets were resuspended in 40 mM Tris-HCl, pH 8.0. To dissolve the PSD (Two Triton) pellet, 0.3% SDS was added. Isolated PSD fractions were checked for the absence of synaptophysin, a presynaptic protein, and concentration of PSD-95 by immunoblotting analysis prior to use in other experiments.

Antibodies-- Antibodies to RICS were prepared by immunizing rabbits with peptides containing amino acids 670-735, 933-1009, 1518-1577 and 1675-1738, respectively. Antibodies were purified by affinity chromatography using columns to which the antigens used for immunization had been linked. Antibodies to N-cadherin, PSD-95 (used for immunoprecipitation and immunoblotting), NR2B (for immunocytochemistry), and Rac1 were from Transduction Laboratories. Antibody to NR2A/2B (for immunoprecipitation and immunoblotting) was obtained from Chemicon and Upstate Biotechnology. Antibodies to synaptophysin and MAP2 were obtained from Sigma. Antibody to NR2B (for immunoprecipitation) and PSD-95 (for immunocytochemistry) was from Upstate Biotechnology. Antibodies to beta -catenin were from Upstate Biotechnology and Transduction Laboratories. Antibodies to RhoA and Cdc42 were from Santa Cruz Biotechnology, Inc.

Immunoprecipitation and Immunoblotting-- Immunoprecipitation and immunoblotting were performed as described elsewhere (49, 50). Briefly, the PSD (One Triton) (50 µg) was first solubilized in 2% SDS in IP buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, 5 mM EDTA, 5 mM EGTA, 1 mM Na3VO4, 50 mM NaF, 0.1 mM phenylmethanesulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin) and then diluted with 5 volumes of IP buffer containing 2% Triton X-100. The lysates were incubated with 10 µg of anti-RICS antibody and 30 µl of protein G-Sepharose (1:1 slurry) overnight at 4 °C. Immunocomplexes were washed once with IP buffer containing 1% Triton X-100, once with IP buffer containing 1% Triton X-100 plus 500 mM NaCl, and finally three times with IP buffer. Immunoprecipitates were subjected to immunoblotting analysis. The blots were probed with the indicated antibodies and then visualized with alkaline phosphatase-conjugated secondary antibodies (Promega).

Primary Neuron Culture and Immunostaining-- Hippocampal primary neuronal cultures prepared from embryonic day 18-19 rat embryos (78) were plated on coverslips coated with poly-L-lysine (50 µg/ml) (5 × 104 cells/well). Cultures were grown in Neurobasal medium (Invitrogen) supplemented with B27 (Invitrogen) and 0.5 mM glutamine. After 3 weeks, cultured hippocampal neurons were fixed with 2% paraformaldehyde in phosphate-buffered saline for 10 min at room temperature and then ice-cold methanol for 10 min at -20 °C. Cells were then double-stained with antibodies to RICS and PSD-95, antibodies to RICS and NR2B, antibodies to RICS and beta -catenin, or antibodies to RICS and MAP2. The staining patterns obtained with antibody to RICS were visualized with fluorescein isothiocyanate-labeled anti-rabbit antibodies (ICN Biomedicals); those obtained with antibodies to MAP2, PSD-95, NR2B, and beta -catenin were visualized with RITC-labeled anti-mouse antibody (ICN Biomedicals). The cells were photographed with a Carl Zeiss LSM510 laser scanning microscope.

GAP Assay-- The GAP domains of RICS (amino acids 1-263) and p50RhoGAP (amino acids 189-439) fused to GST were expressed in E. coli. His6-tagged Rho GTPases (0.1 µg of each protein) generated by the baculovirus system were preincubated with [gamma -32P]GTP (3 µCi, 6000 Ci/mmol) in a mixture (20 µl) containing 20 mM Tris-HCl, pH 7.5, 25 mM NaCl, 5 mM EDTA, 0.1 mM dithiothreitol for 10 min at 30 °C. After the addition of MgCl2 (final concentration 20 mM), 10 nM GST, GST-RICS-GAP, or GST-p50RhoGAP in GAP buffer (20 mM Tris-HCl, pH 7.5, 0.1 mM dithiothreitol, 1 mM GTP, 0.86 mg/ml bovine serum albumin) was added to the mixture and incubated at room temperature, and 10-µl samples were removed at 0, 2, 4, and 6 min, diluted in 1 ml of ice-cold Buffer B (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM MgCl2), and filtered through nitrocellulose membranes prewetted with Buffer B. After washing twice with 10 ml of ice-cold Buffer B, the radioactivity remaining on the filter was determined.

Phosphatase Assay-- Lysate were prepared from mouse brain, and immunoprecipitation experiments were performed as described above. The immunoprecipitates were washed three times with BAP buffer (20 mM Tris-HCl, pH 8.0, 1 mM MgCl2) and incubated at 30 °C for 5 min and then bacterial alkaline phosphatase (TAKARA) was added to the reaction mixtures and incubated for 5 min before termination by SDS-PAGE sample buffer.

RBD and PBD Assay-- The Rho-binding domain (RBD; amino acids 2-89) of mouse rhotekin and p21-binding domain (PBD; amino acids 65-136) of mouse PAK-3 were prepared as GST fusion proteins. NIH3T3 cells infected with Ret-RICS were lysed with lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1 mM phenylmethanesulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 0.5% sodium deoxycholate, 0.1% SDS). The GTP-bound form of endogenous Rho GTPases was affinity-purified from the clarified lysates containing 700 µg (for RhoGAP), 100 µg (for RacGAP), or 200 µg (for Cdc42GAP) of protein with 20 µg of GST-RBD or GST-PBD. Bound Rho, Rac1, and Cdc42 were detected by immunoblotting with antibodies against RhoA, Rac1, and Cdc42, respectively (41, 42).

Phosphorylation of RICS by Purified CaMKII-- PSD fractions were solubilized with IP buffer containing 1% Triton X-100, 0.2% SDS, and 0.5% sodium deoxycholate for 30 min at room temperature and centrifuged at 201,800 × g for 1 h. The supernatant was subjected to immunoprecipitation with anti-RICS antibody. Immunoprecipitated RICS (about 1 µg/ml) in 50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 10 mM dithiothreitol, and 30 µM [gamma -32P]ATP was incubated at 30 °C for 1 h with gentle agitation in the presence or absence of purified rat brain CaMKII (1 µg/ml) (Calbiochem), Ca2+ (0.4 mM EGTA/0.7 mM CaCl2 or 0.4 mM EGTA), 1 µg of bovine brain calmodulin (Chemicon), and 30 µM CaMKII inhibitor KN-93 (Calbiochem) in the total volume of 100 µl. For the GAP assay, phosphorylation of immunoprecipitated RICS was performed at 30 °C for 2 h using 2 mM ATP. Phosphorylated RISC was washed three times with GAP buffer and subjected to in vitro GAP assay as described above.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Molecular Cloning of the RICS cDNA-- We screened a mouse 17-day-embryo cDNA library by the yeast two-hybrid system using the armadillo repeats 10-12 of mouse beta -catenin as bait and obtained a cDNA fragment of a novel gene, which we have designated RICS (Fig. 1). Addition of the nucleotide sequence of the upstream portion of the clone obtained by the 5'-rapid amplification of cDNA ends system revealed a composite sequence containing a 5,220-bp-long open reading frame, encoding a predicted protein of 1740 amino acids. Its human homolog corresponds to KIAA0712 and contains a 5214-bp-long open reading frame, encoding a predicted protein of 1738 amino acids (Fig. 1A). The predicted amino acid sequence of RICS revealed that its amino-terminal region possesses striking amino acid homology to several GAPs that are modulators of the Rho family of small G-proteins (Fig. 1, B and C). In particular, the GAP domain of RICS shares 67.9% identity with that of CdGAP (35) (Fig. 1, B and C). In addition, the central region of RICS contains three Pro-rich sequences, each of which conforms to the Src homology 3-binding motif (Fig. 1A).


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 1.   Structure of RICS. A, predicted amino acid sequence of RICS. Human RICS is a 1738-amino acid protein that contains a RhoGAP domain (box) and three proline-rich motifs (bold). The region required for binding to beta -catenin (amino acids 1182-1371) is underlined. The axonal sorting motifs have dashed underlines. B, alignment of the amino acid sequences of the RhoGAP domains of RICS, CdGAP, p50RhoGAP, and p190RhoGAP. Identical residues are shown in bold type. The residues that participate in catalysis (*) and in the interaction with Rho family GTPase (+) are indicated. C, schematic representation of RICS and the Rho GTPases.

Expression of RICS mRNA and Protein-- Northern blot analysis detected a doublet 9.8- and 10-kb mRNA. Both bands were detected at high levels in mouse kidney, brain, testis, and heart and at low levels in skeletal muscle, liver, lung, and spleen (Fig. 2A).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   RICS mRNA and protein. A, expression of RICS mRNA in mouse adult tissues. Multiple tissue northern (MTN) blots of mouse adult tissues (Clontech) were probed with a cDNA encoding RICS. As a control, expression of actin mRNA was also examined. The positions of the RICS and actin mRNAs are indicated by arrowheads. B, identification and characterization of the RICS protein. Left panel, lanes 1 and 2, in vitro translated RICS was subjected to immunoblotting with total IgG from nonimmunized rabbit (lane 1) or anti-RICS antibody (lane 2). Lanes 3 and 4, Myc-tagged RICS exogenously expressed in 293 cells was immunoprecipitated with nonimmune IgG (lane 3) or anti-Myc antibody (lane 4) and then immunoblotted with anti-RICS antibody. Lanes 5 and 6, a lysate from DLD-1 cells was subjected to immunoblotting with anti-RICS antibody (lane 5) or nonimmune IgG (lane 6). Right panel, lane 1, a lysate from mouse brain was subjected to immunoblotting with anti-RICS antibody. Lanes 2-6, lysates from mouse brain were subjected to immunoprecipitation followed by immunoblotting with anti-RICS antibody. Lane 2, total IgG of nonimmune rabbit instead of anti-RICS antibody was used for immunoprecipitation. Lanes 4 and 5, the RICS immunoprecipitates were treated with bacterial alkaline phosphatase in the absence (lane 4) or presence of beta -glycerophosphate (10 µM) (lane 5). C, RICS is enriched in the PSD in mouse brain. Mouse brain was fractionated as described under "Experimental Procedures." Mouse brain homogenate (25 µg), the synaptosome fraction (25 µg), PSD extracted once (One Triton; 2.5 µg) or twice with Triton X-100 (Two Triton; 2.5 µg), and PSD extracted once with Triton X-100 followed by N-lauroylsarcosinate (One Triton + Sarcosyl; 2.5 µg) were subjected to immunoblotting analysis with antibodies to RICS, PSD-95, or synaptophysin.

To identify the gene product, we generated antibodies to the carboxyl-terminal portion (amino acids 1518-1578) of RICS and confirmed that the antibody reacts specifically with RICS generated by in vitro translation (Fig. 2B). The antibody also recognized Myc-tagged RICS that was exogenously expressed in 293 cells and immunoprecipitated with anti-Myc antibody (Fig. 2B). Immunoblotting analysis of a lysate from mouse brain and human colorectal tumor DLD-1 cells with anti-RICS antibody but not total IgG from nonimmunized rabbit detected a doublet of 250 and 210 kDa (see Fig. 2B and Fig. 3C). Also, immunoprecipitation-immunoblotting experiments with anti-RICS antibody but not total IgG of nonimmunized rabbit detected both 250- and 210-kDa proteins (Fig. 2B), and precipitation of these proteins was inhibited by preincubation of the antibody with the antigen used for immunization (Fig. 3C). Furthermore, three other antibodies raised against different epitopes also detected the 250- and 210-kDa proteins (data not shown). These results suggest that the 250- and 210-kDa proteins identified by the anti-RICS antibodies are the RICS gene products. The nature of the doublet is currently under investigation. In addition, the migration of the 250- and 210-kDa RICS proteins was accelerated by phosphatase treatment of RICS immunoprecipitates (Fig. 2B). However, the migration of these proteins was not increased by phosphatase treatment in the presence of a phosphatase inhibitor, beta -glycerophosphate. These results suggest that RICS is phosphorylated in living cells.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Association of RICS with beta -catenin, N-cadherin, NMDA receptors, and PSD-95. A, mapping of the regions in RICS required for interaction with beta -catenin. Deletion constructs of RICS were analyzed for their ability to interact with beta -catenin in the two-hybrid system. Schematic representation of RICS deletion mutants and corresponding beta -catenin-binding activities are shown. +, detectable activity; ±, very weak activity; -, no detectable activity. B, association of RICS with beta -catenin in vitro. In vitro translated [35S]methionine-labeled full-length RICS or a RICS fragment lacking amino acids 1182-1371 were incubated with GST-beta -catenin-Sepharose. The bound proteins were analyzed by SDS-PAGE followed by autoradiography. Ten % of in vitro translated proteins used for pull-down assays were applied to each Input lane. WT, wild-type. C, association of RICS with beta -catenin in vivo. Lysates prepared from mouse brain were subjected to immunoprecipitation (IP) with the antibodies indicated, fractionated by SDS-PAGE, and immunoblotted with the antibodies indicated. Ag+, antibodies were preincubated with antigens before use in immunoprecipitation. In lanes labeled Lysate, 10% of lysates used for immunoprecipitation were applied. Control IgG, preimmune control serum was used for immunoprecipitation. WB, Western blot. D, the RICS-beta -catenin complex is associated with N-cadherin, NMDA-R, and PSD-95 in vivo. Lysates prepared from the PSD of mouse brain were subjected to immunoprecipitation with the indicated antibodies, fractionated by 6% SDS-PAGE, and immunoblotted with the indicated antibodies. Ag+, antibodies were preincubated with antigens before use in immunoprecipitation. In lanes labeled Lysate, 5% of lysates used for immunoprecipitation were applied.

RICS Is Present in the PSD Fraction-- We next examined the subcellular localization of RICS by subcellular fractionation of mouse brain (Fig. 2C). Similar to PSD-95, RICS was found to be concentrated in the synaptosomes and in the Triton X-100 insoluble fraction (One-Triton and Two-Triton PSD; see "Experimental Procedures"). Most of RICS was present in the PSD fraction even after extraction with N-lauroylsarcosinate, suggesting that RICS is tightly bound to the core structure of the PSD.

RICS Binds to beta -Catenin in Vitro-- The minimal fragment of RICS obtained in the two-hybrid screen contained the carboxyl-terminal 557 amino acids. Two-hybrid assays using deletion fragments of RICS further confirmed that a fragment containing amino acids 1182-1371 was positive for interaction with beta -catenin, whereas a fragment lacking this region was not (Fig. 3A). A fragment containing amino aids 1182-1303 was weakly positive. Consistent with these results, RICS generated by in vitro translation was found to specifically interact with beta -catenin fused to GST (GST-beta -catenin), whereas RICS lacking amino acids 1182-1371 did not interact with GST-beta -catenin (Fig. 3B).

RICS Interacts with beta -Catenin in Vivo-- To examine whether RICS is associated with beta -catenin in vivo, we subjected a lysate from mouse brain to immunoprecipitation with anti-RICS antibody and then immunoblotted with anti-beta -catenin antibody. As shown in Fig. 3C, RICS was found to coprecipitate with beta -catenin, and this coprecipitation was inhibited by preincubation of anti-RICS antibody with the antigen used for immunization. Also, immunoprecipitation of the lysate with anti-beta -catenin and subsequent immunoblotting with anti-RICS antibody revealed an association between RICS and beta -catenin (Fig. 3C). Preincubation of the anti-beta -catenin antibody with the antigen prevented coprecipitation of beta -catenin and RICS. These results suggest that RICS interacts with beta -catenin in vivo.

The RICS-beta -Catenin Complex Is Associated with N-Cadherin, NMDA Receptors, and PSD-95 in Vivo-- Because beta -catenin is known to be associated with the cadherin family of proteins, we examined whether the RICS-beta -catenin complex is associated with E-cadherin and N-cadherin. Immunoblot analysis of the RICS immunoprecipitates with anti-E-cadherin and anti-N-cadherin antibodies revealed that E-cadherin (data not shown) and N-cadherin (Fig. 3D) both coprecipitate with RICS. Immunoblot analysis of the E-cadherin and N-cadherin immunoprecipitates with anti-RICS antibody further confirmed that E-cadherin and N-cadherin coprecipitate with RICS (data not shown). Coprecipitation of these proteins was not observed when anti-RICS antibody preincubated with the antigen was used for immunoprecipitation (Fig. 3D). These results suggest that RICS, beta -catenin, and E-cadherin/N-cadherin are contained in the same complex in vivo.

The beta -catenin-cadherin complex has been reported to be linked to the NMDA-R-PSD-95 complex (12). Therefore, we next examined whether RICS is contained in the NMDA receptor-PSD-95 complex. When the RICS immunoprecipitate was subjected to immunoblot analysis with anti-NR2A/2B and anti-PSD-95 antibodies, respectively, both NR2A/2B and PSD-95 were found to coimmunoprecipitate with RICS (Fig. 3D). Immunoblot analysis of the NR2A/2B and PSD-95 immunoprecipitates with anti-RICS antibody also showed that NR2A/2B and PSD-95 coprecipitate with RICS (data not shown). However, the amounts of RICS detected in the NR2A/2B and PSD-95 immunoprecipitates were small, presumably because NR2A/2B and PSD-95 are present in a great excess over RICS. On the other hand, focal adhesion kinase was not coimmunoprecipitated with RICS (Fig. 3D). Taken together, theses results suggest that RICS, beta -catenin, N-cadherin, NMDA receptor, and PSD-95 may be contained in the same complex in vivo.

RICS Is Localized to the Synapse in Cultured Hippocampal Neurons-- Immunofluorescent staining of rat hippocampal neuronal cultures was performed to examine the colocalization of RICS and PSD-95. When hippocampal cells were cultured for 3 weeks, RICS was expressed in MAP2-positive neurons and glial fibrillary acidic protein-positive glial cells. In neuronal cells, dendrites were brightly labeled by anti-RICS antibody and appeared as dots (Fig. 4, A-D). This punctate staining for RICS coincided with those observed for NR2B and PSD-95, although some fraction of NR2B and PSD-95 puncta did not costain for RICS (Fig. 4, H-M). Numerous RICS clusters colocalized with beta -catenin clusters (Fig. 4, E-G). These staining patterns were not detected when antibody was preadsorbed with an excess amount of the antigens used for immunization.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Colocalization of RICS with beta -catenin, PSD-95, and NMDA-R in cultured rat hippocampal neurons. Hippocampal neurons cultured for 3 weeks were double-labeled with antibodies to RICS and MAP2 (A-D), antibodies to RICS and beta -catenin (E-G), antibodies to RICS and PSD-95 (H-J), or antibodies to RICS and NR2B (K-M). C, control experiments performed with anti-RICS antibody that had been preabsorbed with antigen. Scale bars, 10 µm.

RICS Possesses GAP Activity for Rho GTPases in Vitro-- Because the amino acid sequence of RICS has homology to the GAPs for Rho GTPases, we examined whether RICS also functions as a GAP for Rho, Rac1, and/or Cdc42. When the GAP domain of RICS fused to GST was incubated with RhoA, Rac1, or Cdc42 bound to [gamma -32P]GTP, it was found to stimulate hydrolysis of GTP to GDP (Fig. 5A). Arg-58 and Lys-98 of the GAP domain of RICS correspond to the conserved amino acid residues of RhoGAPs, which are known to be required for GAP activity per se and for interaction with Rho GTPases, respectively (36, 37). We therefore generated mutated versions of RICS, designated RICS-R58A and -K98A, in which Arg-58 and Lys-98, respectively, were replaced with Ala. Unexpectedly, RICS-R58A showed GAP activity against RhoA, Rac1, and Cdc42, although RICS-K98A was inactive (Fig. 5A). After further considering the three-dimensional structure of the Rho GTPases-GAP complexes (38-40), we then replaced Arg-58 with Ile and Met, respectively, and generated RICS-R58I and -R58M. As expected these mutants were found to possess no GAP activity with respect to RhoA, Rac1, or Cdc42 (Fig. 5B; see below). These results indicate that RICS possesses GAP activity toward RhoA, Rac1, and Cdc42.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   RICS possesses GAP activity for Rho GTPases. A, time course of GTPase activity of baculoviral His6-RhoA, -Rac1, and -Cdc42 in the presence or absence of the GAP domain of RICS, -RICS-R58A, -RICS-K98A, or -p50RhoGAP fused to GST. B, the levels of active GTP-bound RhoA, Rac1, and Cdc42 were measured in NIH3T3 cells infected with a control retrovirus or a retrovirus encoding either wild-type or mutant RICS. Wild-type and mutant RICSs were expressed at comparable levels (data not shown). GTPase activities of RhoA, Rac1, and Cdc42 were assessed using a GST fusion protein derived from Rhotekin (RBD), which selectively binds GTP-bound RhoA, or PAK-3 (PBD), which selectively binds GTP-bound Rac1 and Cdc42. GST-RBD and -PBD precipitates were immunoblotted with antibodies to RhoA, Rac1, and Cdc42.

RICS Possesses GAP Activity for Cdc42 and Rac1 in Vivo-- We next examined whether RICS exhibits GAP activity toward Rho GTPases in vivo. NIH3T3 cells were infected with a retrovirus encoding Myc-tagged RICS (Ret-RICS), and GAP activity of RICS was examined by RBD or PBD assay (41, 42). We found that expression of RICS resulted in decreases in the levels of the active forms of Cdc42 and Rac1, whereas expression of the inactive mutants RICS-R58I or -R58M did not (Fig. 5B). On the other hand, RICS induced a slight reduction in the level of the active form of RhoA. Under these experimental conditions, the total amount of Cdc42, Rac1, and RhoA remained constant. These results suggest that RICS possesses GAP activity for Cdc42 and Rac1 in vivo.

RICS Is Phosphorylated by CaMKII-- RICS possesses 24 consensus sites (RXX(S/T)) for phosphorylation by CaMKII. We therefore examined whether RICS is phosphorylated by purified CaMKII in the presence of Ca2+ and/or calmodulin. As shown in Fig. 6A, RICS immunoprecipitated from the PSD fraction of mouse brain lysate was phosphorylated by purified CaMKII in a Ca2+- and calmodulin-dependent manner (Fig. 6A). Phosphorylation of RICS was inhibited by the addition of the CaMKII inhibitor KN-93 to the kinase reaction mixture (Fig. 6A). These results suggest that RICS is phosphorylated by CaMKII.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   The GAP activity of RICS is inhibited by phosphorylation by CaMKII. A, phosphorylation of RICS by purified CaMKII. RICS immunoprecipitated (IP) with anti-RICS antibody (lanes 1-5) or preimmune IgG (lanes 6 and 7) from the PSD fraction of mouse brain lysate was phosphorylated in phosphorylation buffer containing the indicated combinations of Ca2+, calmodulin, and the CaMKII inhibitor KN-93 (30 µM). After incubation at 30 °C for 1 h, the samples were subjected to SDS-PAGE and autoradiography. B, phosphorylation of RICS by purified CaMKII inhibits its GAP activity against Cdc42. RICS was immunoprecipitated with anti-RICS antibody (lanes 1-5) or preimmune IgG (lanes 6 and 7) from the PSD fraction of mouse brain lysate, phosphorylated by purified CaMKII as in A at 30 °C for 2 h, and then subjected to an in vitro GAP assay. Data were obtained from five independent experiments. Phosphorylation conditions corresponding to each graph are indicated in the right side.

The GAP Activity of RICS Is Inhibited by Phosphorylation by CaMKII-- We next investigated whether phosphorylation by CaMKII affects the GAP activity of RICS against Cdc42. RICS immunoprecipitated from the PSD fraction of mouse brain lysate was phosphorylated by purified CaMKII, and its GAP activity against Cdc42 was measured. The GAP activity of RICS was inhibited following phosphorylation in the presence of Ca2+ and calmodulin (Fig. 6B). Inhibition of GAP activity was blocked when the phosphorylation reaction was performed in the presence of KN-93 or a nonhydrolyzable ATP analog, AMP-PNP. Furthermore, the GAP activity of RICS was not inhibited by phosphorylation in the absence of Ca2+ and calmodulin. These results imply that the GAP activity of RICS is inhibited by CaMKII-mediated phosphorylation.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the present study, we found that beta -catenin interacts with RICS via armadillo repeats 10-12. Furthermore, we showed that RICS is enriched in the PSD fraction and coimmunoprecipitates with N-cadherin, PSD-95, and NMDA receptors from the PSD of mouse brain. Consistent with this result, RICS, PSD-95, and NMDA receptors colocalized at the synapses in cultured hippocampal neurons. In addition, in vitro pull-down assays showed that in vitro translated RICS weakly interacts with NR2A/2B and PSD-95 but not with NR1 (data not shown). Although these weak interactions were reproducibly detected in our experimental conditions, we do not know whether these interactions are physiologically important. In any case, these results suggest that RICS, beta -catenin, N-cadherin, PSD-95, and NMDA receptors are contained within the same complex in vivo. The PSD-95 family of proteins interacts with various proteins, including DAP (hDLG-associated protein)/SAPAP (synapse-associated protein 90-associated protein)/GKAP (guanylate kinase-associated protein) (43-46), SPAL/SPAR (47, 48), synGAP (49, 50), Kalirin-7 (51), CRIPT (52), neuroligin (53), and nNOS (54). Thus, RICS may be contained in a multicomponent complex consisting of adhesion proteins, NMDA receptors, and other various structural and signaling molecules.

We demonstrated that RICS possesses GAP activity for Ccd42 and Rac1. This result is consistent with the observation that the GAP domain of RICS is highly homologous to that of CdGAP, which also possesses GAP activity for Cdc42 and Rac1 (35). The Rho GTPases regulate the actin cytoskeleton (55, 56) and play an important role in the maintenance and reorganization of dendritic spines (57, 58). Rac1 is required for the maintenance of dendritic spines, whereas elevation of RhoA activity leads to pronounced simplification of dendritic branch patterns (59). Furthermore, Karilin-7, a guanine nucleotide exchange factor for Rac1, has been reported to be a regulator of the postsynaptic actin cytoskeleton (51). On the other hand, it has been reported that overexpression of either an active or dominant-negative form of Cdc42 does not induce significant changes in the maintenance of spine density or morphology (60). Thus, RICS may be involved in the maintenance and reorganization of dendritic spines through its GAP activity toward Rac1.

It has been shown that NMDA receptor signaling influences dendritic branching, and this regulation involves Rho GTPases that are contained in the NMDA receptor complex (61). In addition, it has been reported that PSD-95 is involved in regulating spine structure and number; overexpression of PSD-95 in cultured hippocampus neurons leads to increases in the size and number of dendritic spines (62). Therefore, the fact that RICS is contained in the NMDA receptor-PSD-95 complex raises the possibility that activation of NMDA receptors leads to RICS-mediated regulation of Rho GTPase. In this regard, it is interesting that RICS was found to be a substrate for CaMKII, and its GAP activity is inhibited by phosphorylation by CaMKII.

CaMKII is highly concentrated in the PSD and plays a key role in LTP (34, 63-67). CaMKII is activated following Ca2+ influx through the NMDA receptors during LTP induction and potentiates synaptic efficacy (68-70). Stimulation by Ca2+/calmodulin induces binding of CaMKII to the cytoplasmic carboxyl-terminus of NR1, NR2A, and NR2B (71-73), and the interaction with NR2B locks CaMKII into an active conformation (74). Hence, it is interesting to speculate that CaMKII activated by Ca2+ entry through NMDA receptors inactivates RICS, which in turn increases the active GTP-bound forms of Cdc42 and Rac1. This would thereby induce, for example, remodeling of dendritic spines. Thus, RICS may play a role in the NMDA receptor-mediated signal transduction pathway and be involved in the regulation of synaptic plasticity.

The adhesion proteins are not simply basic structural scaffolds that hold the synapse and its components together. For example, N-cadherin distribution can be dynamically regulated by neuronal activity, in a manner requiring the NMDA receptors (7). It has been postulated that the function of N-cadherin is to transiently change spine morphology. Indeed, inhibition of cadherin activity has been shown recently (18) to alter dendritic spine morphology, suggesting that cadherins function as regulators of synaptic plasticity by modulating this morphology. On the other hand, it has been reported that cadherin-mediated junction formation activates Rac1 (75) and that Rac1 is required for the maintenance of dendritic spines (59). These findings raise the possibility that the cadherin system regulates spine morphology by regulating Rho GTPases. Hence, it is possible that RICS contained in the N-cadherin-beta -catenin complex is involved in N-cadherin-mediated regulation of spine morphology.

It has been reported recently (10) that neural activity induces redistribution of beta -catenin from dendritic shafts into spines and increases its association with cadherins, thereby promoting changes in synaptic structure and function (10). Thus, it would be interesting to determine whether RICS is also induced to redistribute together with beta -catenin into spines or if RICS associates with redistributed beta -catenin in the PSD. The redistribution of beta -catenin is mimicked or prevented, respectively, by a tyrosine kinase or phosphatase inhibitor (10). Furthermore, Murase et al. (10) demonstrated that a point mutation in beta -catenin Tyr-654 alters spine-shaft distribution; a mutant beta -catenin, in which Tyr-654 is replaced with Phe, thereby abrogating phosphorylation, is concentrated in spines, whereas a mutant beta -catenin, in which Tyr-654 is replaced with Glu to mimic phosphorylation, accumulates in dendritic shafts. Interestingly, RICS interacts with the armadillo repeats 10-12 of beta -catenin and Tyr-654 resides in armadillo repeat 12. It would therefore be interesting to examine whether phosphorylation of beta -catenin Tyr-654 regulates its interaction with RICS.

In conclusion, our results suggest that RICS is involved in the synaptic adhesion- and NMDA receptor-mediated organization of cytoskeletal networks and signal transduction. We speculate that RICS may regulate dendritic spine morphology and strength by regulating Cdc42 and Rac1.

During the revision of this paper, Nakamura et al. (79) and Moon et al. (80) reported the identification of Grit and p200RhoGAP, respectively, which are identical to RICS. Nakamura et al. (79) have shown that Grit may regulate neurite extension through association with the TrkA receptor and N-Shc and CrkL/Crk adapter molecules. Moon et al. (80) have demonstrated that p200RhoGAP may be involved in the regulation of neurite outgrowth, and its activity may be regulated through an interaction with Src-like tyrosine kinases. It has been shown that Grit prefers RhoA and Cdc42 to Rac1 whereas p200RhoGAP prefers RhoA and Rac1. Discrepancies between three papers (Refs. 79 and 80 and this article) are currently under investigation in our laboratory.

    ACKNOWLEDGEMENTS

We thank T. Nagase for the KIAA0712 cDNA clone and C. Toyoshima for helpful discussion.

    FOOTNOTES

* This work was supported by grants-in-aid for Scientific Research on Priority Areas (C), Cancer and Advanced Brain Science Project, from the Ministry of Education, Culture, Sports, Science and Technology, Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Contributed equally to this work.

|| To whom correspondence should be addressed. Tel.: 81-3-5841-8483; Fax: 81-3-3841-8482; E-mail: akiyama@iam.u-tokyo.ac.jp.

Published, JBC Papers in Press, January 16, 2003, DOI 10.1074/jbc.M208872200

    ABBREVIATIONS

The abbreviations used are: LTP, long term potentiation; PSD, postsynaptic density; NMDA, N-methyl-D-aspartate; NMDA-R, NMDA receptor; CaMKII, calmodulin-dependent protein kinase II; GST, glutathione S-transferase; IP, immunoprecipitation; RBD, Rho-binding domain; PBD, p21-binding domain; AMP-PNP, adenosine 5'-(beta ,gamma -imino)triphosphate or adenosine 5'-(beta ,gamma -iminotriphosphate); GAP, GTPase-activating protein; NR, NMDA receptor; MAP, microtubules-associated protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Engert, F., and Bonhoeffer, T. (1999) Nature 399, 66-70[CrossRef][Medline] [Order article via Infotrieve]
2. Toni, N., Buchs, P. A., Nikonenko, I., Bron, C. R., and Muller, D. (1999) Nature 402, 421-425[CrossRef][Medline] [Order article via Infotrieve]
3. Lendvai, B., Stern, E. A., Chen, B., and Svoboda, K. (2000) Nature 404, 876-881[CrossRef][Medline] [Order article via Infotrieve]
4. Toni, N., Buchs, P. A., Nikonenko, I., Povilaitite, P., Parisi, L., and Muller, D. (2001) J. Neurosci. 21, 6245-6251[Abstract/Free Full Text]
5. Yuste, R., and Bonhoeffer, T. (2001) Annu. Rev. Neurosci. 24, 1071-1089[CrossRef][Medline] [Order article via Infotrieve]
6. Luscher, C., Nicoll, R. A., Malenka, R. C., and Muller, D. (2000) Nat. Neurosci. 3, 545-550[CrossRef][Medline] [Order article via Infotrieve]
7. Tanaka, H., Shan, W., Phillips, G. R., Arndt, K., Bozdagi, O., Shapiro, L., Huntley, G. W., Benson, D. L., and Colman, D. R. (2000) Neuron 25, 93-107[Medline] [Order article via Infotrieve]
8. Gardoni, F., Schrama, L. H., Kamal, A., Gispen, W. H., Cattabeni, F., and Di Luca, M. (2001) J. Neurosci. 21, 1501-1509[Abstract/Free Full Text]
9. El-Husseini Ael, D., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q., Prange, O., Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R. A., and Bredt, D. S. (2002) Cell 108, 849-863[Medline] [Order article via Infotrieve]
10. Murase, S. M., Mosser, E., and Schuman, E. M. (2002) Neuron 35, 91-105[Medline] [Order article via Infotrieve]
11. Walikonis, R. S., Jensen, O. N., Mann, M., Provance, D. W., Jr., Mercer, J. A., and Kennedy, M. B. (2000) J. Neurosci. 20, 4069-4080[Abstract/Free Full Text]
12. Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., and Grant, S. G. (2000) Nat. Neurosci. 3, 661-669[CrossRef][Medline] [Order article via Infotrieve]
13. Takeichi, M. (1986) Dev. Biol. 2, 373-388
14. Uchida, N., Honjo, Y., Johnson, K. R., Wheelock, M. J., and Takeichi, M. (1996) J. Cell Biol. 135, 767-779[Abstract]
15. Murase, S., and Schuman, E. M. (1999) Curr. Opin. Cell Biol. 11, 549-553[CrossRef][Medline] [Order article via Infotrieve]
16. Tang, L., Hung, C. P., and Schuman, E. M. (1998) Neuron 20, 1165-1175[Medline] [Order article via Infotrieve]
17. Bozdagi, O., Shan, W., Tanaka, H., Benson, D. L., and Huntley, G. W. (2000) Neuron 28, 245-259[Medline] [Order article via Infotrieve]
18. Togashi, H., Abe, K., Mizoguchi, A., Takaoka, K., Chisaka, O., and Takeichi, M. (2002) Neuron 35, 77-89[Medline] [Order article via Infotrieve]
19. Ozawa, M., Baribault, H., and Kemler, R. (1989) EMBO J. 8, 1711-1717[Abstract]
20. Rimm, D. L., Koslov, E. R., Kebriaei, P., Cianci, C. D., and Morrow, J. S. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8813-8817[Abstract]
21. Benson, D. L., and Tanaka, H. (1998) J. Neurosci. 18, 6892-6904[Abstract/Free Full Text]
22. Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M., et al.. (1992) Nature 358, 36-41[CrossRef][Medline] [Order article via Infotrieve]
23. Meguro, H., Mori, H., Araki, K., Kushiya, E., Kutsuwada, T., Yamazaki, M., Kumanishi, T., Arakawa, M., Sakimura, K., and Mishina, M. (1992) Nature 357, 70-74[CrossRef][Medline] [Order article via Infotrieve]
24. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., and Seeburg, P. H. (1992) Science 256, 1217-1221[Medline] [Order article via Infotrieve]
25. Kornau, H. C., Schenker, L. T., Kennedy, M. B., and Seeburg, P. H. (1995) Science 269, 1737-1740[Medline] [Order article via Infotrieve]
26. Niethammer, M., Kim, E., and Sheng, M. (1996) J. Neurosci. 16, 2157-2163[Abstract]
27. Lau, L. F., Mammen, A., Ehlers, M. D., Kindler, S., Chung, W. J., Garner, C. C., and Huganir, R. L. (1996) J. Biol. Chem. 271, 21622-21628[Abstract/Free Full Text]
28. Muller, B. M., Kistner, U., Kindler, S., Chung, W. J., Kuhlendahl, S., Fenster, S. D., Lau, L. F., Veh, R. W., Huganir, R. L., Gundelfinger, E. D., and Garner, C. C. (1996) Neuron 17, 255-265[Medline] [Order article via Infotrieve]
29. Kennedy, M. B. (2000) Science 290, 750-754[Abstract/Free Full Text]
30. Scannevin, R. H., and Huganir, R. L. (2000) Nat. Rev. Neurosci. 1, 133-141[CrossRef][Medline] [Order article via Infotrieve]
31. Sheng, M. (2001) J. Cell Sci. 114, 1251[Abstract/Free Full Text]
32. Sheng, M. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 7058-7061[Abstract/Free Full Text]
33. Hering, H., and Sheng, M. (2001) Nat. Rev. Neurosci. 2, 880-888[CrossRef][Medline] [Order article via Infotrieve]
34. Lisman, J., Schulman, H., and Cline, H. (2002) Nat. Rev. Neurosci. 3, 175-190[CrossRef][Medline] [Order article via Infotrieve]
35. Lamarche-Vane, N., and Hall, A. (1998) J. Biol. Chem. 273, 29172-29177[Abstract/Free Full Text]
36. Barrett, T., Xiao, B., Dodson, E. J., Dodson, G., Ludbrook, S. B., Nurmahomed, K., Gamblin, S. J., Musacchio, A., Smerdon, S. J., and Eccleston, J. F. (1997) Nature 385, 458-461[CrossRef][Medline] [Order article via Infotrieve]
37. Li, R., Zhang, B., and Zheng, Y. (1997) J. Biol. Chem. 272, 32830-32835[Abstract/Free Full Text]
38. Rittinger, K., Walker, P. A., Eccleston, J. F., Smerdon, S. J., and Gamblin, S. J. (1997) Nature 389, 758-762[CrossRef][Medline] [Order article via Infotrieve]
39. Rittinger, K., Walker, P. A., Eccleston, J. F., Nurmahomed, K., Owen, D., Laue, E., Gamblin, S. J., and Smerdon, S. J. (1997) Nature 388, 693-697[CrossRef][Medline] [Order article via Infotrieve]
40. Nassar, N., Hoffman, G. R., Manor, D., Clardy, J. C., and Cerione, R. A. (1998) Nat. Struct. Biol. 5, 1047-1052[CrossRef][Medline] [Order article via Infotrieve]
41. Ren, X. D., Kiosses, W. B., and Schwartz, M. A. (1999) EMBO J. 18, 578-585[Abstract/Free Full Text]
42. del Pozo, M. A., Price, L. S., Alderson, N. B., Ren, X. D., and Schwartz, M. A. (2000) EMBO J. 19, 2008-2014[Abstract/Free Full Text]
43. Satoh, K., Yanai, H., Senda, T., Kohu, K., Nakamura, T., Okumura, N., Matsumine, A., Kobayashi, S., Toyoshima, K., and Akiyama, T. (1997) Genes Cells 2, 415-424[Abstract/Free Full Text]
44. Takeuchi, M., Hata, Y., Hirao, K., Toyoda, A., Irie, M., and Takai, Y. (1997) J. Biol. Chem. 272, 11943-11951[Abstract/Free Full Text]
45. Kim, E., Naisbitt, S., Hsueh, Y. P., Rao, A., Rothschild, A., Craig, A. M., and Sheng, M. (1997) J. Cell Biol. 136, 669-678[Abstract/Free Full Text]
46. Naisbitt, S., Kim, E., Weinberg, R. J., Rao, A., Yang, F. C., Craig, A. M., and Sheng, M. (1997) J. Neurosci. 17, 5687-5696[Abstract/Free Full Text]
47. Roy, B. C., Kohu, K., Matsuura, K., Yanai, H., and Akiyama, T. (2002) Genes Cells 7, 607-617[Abstract/Free Full Text]
48. Pak, D. T., Yang, S., Rudolph-Correia, S., Kim, E., and Sheng, M. (2001) Neuron 31, 289-303[Medline] [Order article via Infotrieve]
49. Kim, J. H., Liao, D., Lau, L. F., and Huganir, R. L. (1998) Neuron 20, 683-691[Medline] [Order article via Infotrieve]
50. Chen, H. J., Rojas-Soto, M., Oguni, A., and Kennedy, M. B. (1998) Neuron 20, 895-904[Medline] [Order article via Infotrieve]
51. Penzes, P., Johnson, R. C., Sattler, R., Zhang, X., Huganir, R. L., Kambampati, V., Mains, R. E., and Eipper, B. A. (2001) Neuron 29, 229-242[Medline] [Order article via Infotrieve]
52. Niethammer, M., Valtschanoff, J. G., Kapoor, T. M., Allison, D. W., Weinberg, T. M., Craig, A. M., and Sheng, M. (1998) Neuron 20, 693-707[Medline] [Order article via Infotrieve]
53. Irie, M., Hata, Y., Takeuchi, M., Ichtchenko, K., Toyoda, A., Hirao, K., Takai, Y., Rosahl, T. W., and Sudhof, T. C. (1997) Science 277, 1511-1515[Abstract/Free Full Text]
54. Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., Wu, Z., Huang, F., Xia, H., Peters, M. F., Froehner, S. C., and Bredt, D. S. (1996) Cell 84, 757-767[Medline] [Order article via Infotrieve]
55. Hall, A. (1998) Science 279, 509-514[Abstract/Free Full Text]
56. Machesky, L. M., and Insall, R. H. (1999) J. Cell Biol. 146, 267-272[Abstract/Free Full Text]
57. Ziv, N. E., and Smith, S. J. (1996) Neuron 17, 91-102[Medline] [Order article via Infotrieve]
58. Luo, L., Hensch, T. K., Ackerman, L., Barbel, S., Jan, L. Y., and Jan, Y. N. (1996) Nature 379, 837-840[CrossRef][Medline] [Order article via Infotrieve]
59. Nakayama, A. Y., Harms, M. B., and Luo, L. (2000) J. Neurosci. 20, 5329-5338[Abstract/Free Full Text]
60. Tashiro, A., Minden, A., and Yuste, R. (2000) Cereb. Cortex 10, 927-938[Abstract/Free Full Text]
61. Li, Z., Van Aelst, L., and Cline, H. T. (2000) Nat. Neurosci. 3, 217-225[CrossRef][Medline] [Order article via Infotrieve]
62. El-Husseini, A. E., Schnell, E., Chetkovich, D. M., Nicoll, R. A., and Bredt, D. S. (2000) Science 290, 1364-1368[Abstract/Free Full Text]
63. Malinow, R., Schulman, H., and Tsien, R. W. (1989) Science 245, 862-866[Medline] [Order article via Infotrieve]
64. Silva, A. J., Paylor, R., Wehner, J. M., and Tonegawa, S. (1992) Science 257, 206-211[Medline] [Order article via Infotrieve]
65. Silva, A. J., Stevens, C. F., Tonegawa, S., and Wang, Y. (1992) Science 257, 201-206[Medline] [Order article via Infotrieve]
66. Stevens, C. F., Tonegawa, S., and Wang, Y. (1994) Curr. Biol. 4, 687-693[Medline] [Order article via Infotrieve]
67. Hinds, H. L., Tonegawa, S., and Malinow, R. (1998) Learn. Mem. 5, 344-354[Abstract/Free Full Text]
68. Pettit, D. L., Perlman, S., and Malinow, R. (1994) Science 266, 1881-1885[Medline] [Order article via Infotrieve]
69. Giese, K. P., Fedorov, N. B., Filipkowski, R. K., and Silva, A. J. (1998) Science 279, 870-873[Abstract/Free Full Text]
70. Ouyang, Y., Kantor, D., Harris, K. M., Schuman, E. M., and Kennedy, M. B. (1997) J. Neurosci. 17, 5416-5427[Abstract/Free Full Text]
71. Gardoni, F., Caputi, A., Cimino, M., Pastorino, L., Cattabeni, F., and Di Luca, M. (1998) J. Neurochem. 71, 1733-1741[Medline] [Order article via Infotrieve]
72. Strack, S., and Colbran, R. J. (1998) J. Biol. Chem. 273, 20689-20692[Abstract/Free Full Text]
73. Leonard, A. S., Lim, I. A., Hemsworth, D. E., Horne, M. C., and Hell, J. W. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3239-3244[Abstract/Free Full Text]
74. Bayer, K. U., De Koninck, P., Leonard, A. S., Hell, J. W., and Schulman, H. (2001) Nature 411, 801-805[CrossRef][Medline] [Order article via Infotrieve]
75. Nakagawa, M., Fukata, M., Yamaga, M., Itoh, N., and Kaibuchi, K. (2001) J. Cell Sci. 114, 1829-1838[Abstract/Free Full Text]
76. Carlin, R. K., Grab, D. J., Cohen, R. S., and Siekevitz, P. (1980) J. Cell Biol. 86, 831-845[Abstract]
77. Cho, K. O., Hunt, C. A., and Kennedy, M. B. (1992) Neuron 9, 929-942[Medline] [Order article via Infotrieve]
78. Margo, C. E., Harman, L. E., and Mulla, Z. D. (1998) Cancer Control 5, 310-316[Medline] [Order article via Infotrieve]
79. Nakamura, T., Komiya, M., Sone, K., Hirose, E., Gotoh, N., Morii, H., Ohta, Y., and Mori, N. (2002) Mol. Cell. Biol. 22, 8721-8734[Abstract/Free Full Text]
80. Moon, S. Y., Zang, H., and Zheng, T. (2003) J. Biol. Chem. 278, 4151-4159[Abstract/Free Full Text]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.